Related Experiment Video
Updated: Aug 23, 2025

11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.3K
Editorial commentary on: "Reduced vs full-dose BCG therapy in bladder cancer: A systematic review and meta-analysis"
D M Carrion1, B Pradere2, F Soria3
1Department of Urology, Torrejon University Hospital, Universidad Francisco de Vitoria, Madrid, Spain; Instituto de Cirugía Urológica Avanzada (ICUA), Clínica CEMTRO, Madrid, Spain; European Association of Urology - Young Academic Urologists (EAU-YAU), Urothelial Carcinoma Working Group.
Actas Urologicas Espanolas
|November 1, 2022
Abstract
No abstract available in PubMed .

